4-[1-Methanesulfonyl-6-((R)-3-methyl-morpholin-4-yl)-8-oxa-3,5-diaza-tricyclo[7.1.1.0*2,7*]undeca-2,4,6-trien-4-yl]-1H-pyrrolo[2,3-c]pyridin-5-ylamine

ID: ALA5192230

Chembl Id: CHEMBL5192230

PubChem CID: 147361420

Max Phase: Preclinical

Molecular Formula: C21H24N6O4S

Molecular Weight: 456.53

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1COCCN1c1nc(-c2c(N)ncc3[nH]ccc23)nc2c1OC1CC2(S(C)(=O)=O)C1

Standard InChI:  InChI=1S/C21H24N6O4S/c1-11-10-30-6-5-27(11)20-16-17(21(32(2,28)29)7-12(8-21)31-16)25-19(26-20)15-13-3-4-23-14(13)9-24-18(15)22/h3-4,9,11-12,23H,5-8,10H2,1-2H3,(H2,22,24)/t11-,12?,21?/m1/s1

Standard InChI Key:  DHIOKYYXEHMPFD-JRBJCYRMSA-N

Alternative Forms

  1. Parent:

    ALA5192230

    ---

Associated Targets(Human)

LoVo (4724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATR Tchem ATR/ATRIP (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.53Molecular Weight (Monoisotopic): 456.1580AlogP: 1.62#Rotatable Bonds: 3
Polar Surface Area: 136.32Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.98CX LogP: 0.92CX LogD: 0.91
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.60Np Likeness Score: -0.10

References

1. Cheng B, Pan W, Xing Y, Xiao Y, Chen J, Xu Z..  (2022)  Recent advances in DDR (DNA damage response) inhibitors for cancer therapy.,  230  [PMID:35051747] [10.1016/j.ejmech.2022.114109]

Source